Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Treadmill walking with eyes covered to aid recovery after a recent stroke

Official title: Efficacy of Treadmill Walking With Hidden Vision for Rehabilitation in the Subacute Phase of Stroke, Randomized Controlled Trial

Run by Centre Hospitalier Régional Metz-Thionville · NCT06972355 · Data updated 2026-11-12

This test sees if walking on a treadmill with your eyes covered, while supported by a harness, helps people within six months after a stroke improve walking speed, balance, and body awareness.

More Subacute Stroke trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment36 (estimated)
SponsorCentre Hospitalier Régional Metz-Thionville
Academic / other
Locations1 site (Metz)
StatusRecruiting
StartedJune 4, 2025
Main results expectedJune 4, 2027
Study endsJuly 19, 2027
Registry record updatedOctober 1, 2025
Trial IDNCT06972355 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) within six months of ischemic or hemorrhagic stroke who have NIHSS 1–15, MoCA 18–30, a physiotherapy prescription, can walk 20 minutes on a treadmill with body-weight support and can maintain standing balance with eyes open and closed for 30 seconds are ideal candidates.

Probably not a fit

Patients with significant visual impairment (best corrected acuity <5/10, homonymous hemianopia or quadrantanopia), those over the 200 kg equipment limit, with unstable severe comorbidities, or who cannot tolerate treadmill walking are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Thirty-six adults within six months of an ischemic or hemorrhagic stroke will be randomized to one of two parallel groups. The experimental group will perform treadmill walking sessions with an opaque mask while using a Lite Gait® body-weight–support harness; the control group will follow the same protocol with eyes open. Each 20-minute walking session is delivered three times per week for six weeks as part of standard rehabilitation. Outcomes include single- and dual-task walking speed, multiple balance measures (center-of-pressure metrics, Romberg quotient, MCTSIB), gait parameters (10-meter walk, step timing and symmetry), and proprioception via joint-position sense testing.

Why it matters

Potential benefit: If successful, this approach could improve walking speed, postural balance, and proprioceptive control after subacute stroke, potentially lowering fall risk and increasing independence.

How similar studies have gone: Vision-deprivation or reduced-vision gait programs have been used in pediatric, geriatric, and chronic stroke groups with limited published evidence of benefit, but this approach has not been specifically studied in the subacute stroke phase.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. 18 years of age or older,
2. With a confirmed diagnosis of ischemic or hemorrhagic stroke in sub-acute phase (stroke less than 6 months old),
3. With NIHSS scores between 1 and 15 and MoCA scores between 18 and 30
4. With a physiotherapy prescription for post Stroke rehabilitation
5. Able to walk for 20 min on a treadmill with weight reduction with pauses, able to maintain bipodal balance, able to maintain bipodal balance with eyes open and closed for 30 seconds,
6. Having expressed free, informed and written consent
7. Affiliated with a social security scheme.

Exclusion Criteria:

1. Patients weighing over 200 kg (maximum weight permitted for use of the Lite Gait ®),
2. Patients with impaired vision:

   1. Best corrected visual acuity below 5/10 on patient examination
   2. Homonymous lateral hemianopia, quadranopia.
3. Inability to physically participate in intensive rehabilitation due to severe, unstabilized and comorbidities (heart, lung, kidney disease or diabetes), severe psychiatric disorders cancer active or under treatment.
4. Patients participating in other interventional research,
5. Pregnant or breast-feeding women,
6. Patients under guardianship.

Where it's running

  • CHR Metz-Thionville Hopital Legouest
    Metz, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.